AOD 9604 completed Phase II human trials (the METAOD program by Metabolic Pharmaceuticals) showing modest but statistically significant weight loss at 1 mg per day orally
Consult a qualified clinician before pursuing any peptide therapy
global ghrelin receptor knockout mice exhibit low fasting blood glucose levels, which are increased when ghrelin receptor expression is selectively restored in nodose ganglia 221
16, 17 GLP-1Rs are expressed not only in pancreatic cells, but also in other organs, such as brain, heart, stomach, muscle and liver
Blood-brain barrier dysfunction underlying Alzheimer's disease is induced by an SSAO/VAP-1-dependent cerebrovascular activation with enhanced A deposition
Prostate cancer (PC) is one of the most commonly and frequently diagnosed malignant solid tumours in men